Sakeena Fatima, MD
Dermatology · Ann Arbor, MINPI 1205332384
Payments from drug & device makers
Across 108 payments — averaging $20.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$476
- Incyte Corporation$303
- Lilly USA, LLC$260
- AbbVie$202
- Johnson & Johnson$157
- E.r. Squibb & Sons, L.L.C.$111
- plus $717 from 20 others
What the payments were for
- Food & beverage$2,225100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 22 | $476 |
| Incyte Corporation | 11 | $303 |
| Lilly USA, LLC | 13 | $260 |
| AbbVie | 10 | $202 |
| Johnson & Johnson | 8 | $157 |
| E.r. Squibb & Sons, L.L.C. | 6 | $111 |
| Sanofi | 5 | $100 |
| Sun Pharmaceutical Industries Inc. | 4 | $78 |
| Dermavant Sciences, Inc. | 3 | $58 |
| Regeneron Healthcare Solutions, Inc. | 3 | $57 |
| Arcutis Biotherapeutics, Inc. | 3 | $55 |
| UCB, Inc. | 2 | $53 |
| Pfizer | 3 | $46 |
| Fresenius Kabi USA, LLC | 2 | $41 |
| Biofrontera Inc. | 2 | $39 |
| Verrica Pharmaceuticals Inc. | 1 | $25 |
| Bristol Myers Squibb | 1 | $25 |
| Blueprint Medicines Corporation | 1 | $23 |
| Botanix SB Inc | 1 | $20 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $20 |
| Journey Medical Corporation | 1 | $18 |
| LEO Pharma Inc. | 1 | $15 |
| Nobelpharma America, LLC | 1 | $15 |
| Amgen | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
| Organon | 1 | $2 |
How this compares
$2,225 in reported general payments places this provider in the 40th percentile of 404 dermatology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Unoready PenSecukinumab | 12 | $88,547 |
| Dupixent PenDupilumab | 13 | $53,234 |
| Tacrolimus | 20 | $2,805 |
| Ketoconazole | 103 | $1,828 |
| Metronidazole | 24 | $1,213 |
| Clobetasol Propionate | 35 | $1,056 |
| Clindamycin Phosphate | 34 | $1,025 |
| Fluocinonide | 33 | $809 |
| Triamcinolone Acetonide | 104 | $742 |
| Betamethasone Dipropionate | 11 | $446 |
| Nystatin | 27 | $327 |
| Mupirocin | 15 | $120 |
| Finasteride | 11 | $98 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Ann Arbor
- Johann GudjonssonAnn Arbor$15.9M
- Mio NakamuraAnn Arbor$1.4M
- Yolanda HelfrichAnn Arbor$217K
- Frank WangAnn Arbor$123K
- Sonam RamaAnn Arbor$72K
- Charles EllisAnn Arbor$53K
- Ali MoiinTroy$9.9M
- Linda Stein GoldWest Bloomfield$7.5M
- Wendy McFaldaClarkston$3.6M
- Kristi HawleyCaledonia$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.